Pancreaticojejunostomy versus pancreaticogastrostomy: systematic review and meta-analysis.

PubWeight™: 1.60‹?› | Rank: Top 4%

🔗 View Article (PMID 17236843)

Published in Am J Surg on February 01, 2007

Authors

Moritz N Wente1, Shailesh V Shrikhande, Michael W Müller, Markus K Diener, Christoph M Seiler, Helmut Friess, Markus W Büchler

Author Affiliations

1: Department of General, Visceral and Trauma Surgery, University of Heidelberg, Heidelberg, Germany.

Associated clinical trials:

Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Cephalic Duodenopancreatectomy (PanAm) | NCT01324856

Isolated Roux Loop Versus Conventional Pancreaticojejunostomy Following Pancreaticoduodenectomy | NCT03671031

Articles citing this

Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol (2011) 1.65

External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg (2007) 1.54

Risk-adapted anastomosis for partial pancreaticoduodenectomy reduces the risk of pancreatic fistula: a pilot study. World J Surg (2010) 1.47

The challenge of pancreatic anastomosis. Langenbecks Arch Surg (2008) 1.41

Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and Long-term Results of a Multicenter Randomized Controlled Trial. Ann Surg (2016) 1.38

Pancreatic fistula after pancreatectomy: evolving definitions, preventive strategies and modern management. World J Gastroenterol (2008) 1.36

Pancreatic fistula after pancreaticoduodenectomy: the impact of a standardized technique of pancreaticojejunostomy. Langenbecks Arch Surg (2007) 1.06

Pancreatic fistula after pancreatectomy: definitions, risk factors, preventive measures, and management-review. Int J Surg Oncol (2012) 1.04

A preoperative predictive score of pancreatic fistula following pancreatoduodenectomy. HPB (Oxford) (2013) 1.00

Which is the best technique for pancreaticoenteric reconstruction after pancreaticoduodenectomy? A critical analysis. Surg Today (2011) 0.98

Reconstruction by Pancreaticogastrostomy versus Pancreaticojejunostomy following Pancreaticoduodenectomy: A Meta-Analysis of Randomized Controlled Trials. Gastroenterol Res Pract (2012) 0.97

Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy: validation of International Study Group of Pancreatic Surgery classification and analysis of risk factors. HPB (Oxford) (2010) 0.97

Isolated Roux loop pancreaticojejunostomy versus pancreaticogastrostomy after pancreaticoduodenectomy: a prospective randomized study. HPB (Oxford) (2014) 0.92

Pancreaticogastrostomy is associated with significantly less pancreatic fistula than pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: a meta-analysis of seven randomized controlled trials. HPB (Oxford) (2014) 0.91

Side-branch intraductal papillary mucinous neoplasms of the pancreatic head/uncinate: resection or enucleation? HPB (Oxford) (2011) 0.88

Pancreaticoduodenectomy for pancreatic cancer: the Verona experience. Surg Today (2011) 0.85

Enteral nutrition in pancreaticoduodenectomy: a literature review. Nutrients (2015) 0.84

Impact of reconstruction methods and pathological factors on survival after pancreaticoduodenectomy. South Asian J Cancer (2013) 0.84

The Study Centre of the German Surgical Society: current trials and results. Langenbecks Arch Surg (2012) 0.84

A new simple and safe technique of end-to-end invaginated pancreaticojejunostomy with transpancreatic U-sutures--early postoperative outcomes in consecutive 88 cases. Langenbecks Arch Surg (2009) 0.83

An easier method for performing a pancreaticojejunostomy for the soft pancreas using a fast-absorbable suture. World J Gastroenterol (2008) 0.83

Ductal adenocarcinoma of the pancreatic head: a focus on current diagnostic and surgical concepts. World J Gastroenterol (2012) 0.83

Early enteral nutrition after pancreatoduodenectomy: a meta-analysis of randomized controlled trials. Langenbecks Arch Surg (2013) 0.82

Outcomes comparing a pancreaticogastrostomy (PG) and a pancreaticojejunostomy (PJ) after a pancreaticoduodenectomy (PD). HPB (Oxford) (2011) 0.82

Modified technique of pancreaticojejunal anastomosis with invagination following pancreaticoduodenectomy: a cohort study. World J Surg (2008) 0.82

How fibrosis influences imaging and surgical decisions in pancreatic cancer. Front Physiol (2012) 0.82

Pancreatogastrostomy versus pancreatojejunostomy for RECOnstruction after partial PANCreatoduodenectomy (RECOPANC): study protocol of a randomized controlled trial UTN U1111-1117-9588. Trials (2012) 0.82

The impact of pancreaticojejunostomy versus pancreaticogastrostomy reconstruction on pancreatic fistula after pancreaticoduodenectomy: meta-analysis of randomized controlled trials. HPB (Oxford) (2014) 0.82

Pancreatoduodenectomy--current status of surgical and perioperative techniques in Germany. Langenbecks Arch Surg (2013) 0.82

Surgery for pancreatic carcinoma: state of the art. Indian J Surg (2011) 0.81

Pancreaticogastrostomy versus pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. Surg Today (2014) 0.81

Total pancreatectomy for pancreatic cancer: indications and operative technique. HPB (Oxford) (2009) 0.80

Total laparoscopic partial pancreatoduodenectomy and reconstruction via laparoscopic pancreatogastrostomy. Langenbecks Arch Surg (2012) 0.80

Application of binding pancreatogastrostomy in laparoscopic central pancreatectomy. World J Surg Oncol (2012) 0.79

Striving for a better operative outcome: 101 pancreaticoduodenectomies. HPB (Oxford) (2008) 0.78

Surgical treatment of the pancreatic stump: preventive strategies of pancreatic fistula after pancreatoduodenectomy for cancer. G Chir (2014) 0.78

Current surgical management of pancreatic cancer. J Gastrointest Oncol (2011) 0.78

Correlation between preoperative imaging and intraoperative risk assessment in the prediction of postoperative pancreatic fistula following pancreatoduodenectomy. World J Surg (2014) 0.77

Laparoscopic central pancreatectomy: Our technique and long-term results in 14 patients. J Minim Access Surg (2015) 0.77

PANasta Trial; Cattell Warren versus Blumgart techniques of panreatico-jejunostomy following pancreato-duodenectomy: Study protocol for a randomized controlled trial. Trials (2016) 0.76

Calculating the risk of a pancreatic fistula after a pancreaticoduodenectomy: a systematic review. HPB (Oxford) (2015) 0.76

Endoscopic management of anastomotic hemorrhage from pancreatogastrostomy. Surg Endosc (2008) 0.76

Pancreatoduodenectomy - preventing complications. Indian J Surg Oncol (2014) 0.75

Pancreatic cancer. BMJ Clin Evid (2010) 0.75

Whipple resection: The need for specialization, standardization and centralization. South Asian J Cancer (2013) 0.75

Canadian practice patterns for pancreaticoduodenectomy. Can J Surg (2015) 0.75

Considerations on pancreatic exocrine function after pancreaticoduodenectomy. World J Gastrointest Oncol (2014) 0.75

Pancreatic fistulae after a pancreatico-duodenectomy: are pancreatico-gastrostomies safer than pancreatico-jejunostomies? An expertise-based trial and propensity-score adjusted analysis. HPB (Oxford) (2014) 0.75

In search of the best reconstructive technique after pancreaticoduodenectomy: pancreaticojejunostomy versus pancreaticogastrostomy. Can J Surg (2015) 0.75

Surgery for Pancreatic and Periampullary Carcinoma. Indian J Surg (2015) 0.75

Pathophysiology after pancreaticoduodenectomy. World J Gastroenterol (2015) 0.75

Peri-operative outcomes for pancreatoduodenectomy in India: a multi-centric study. HPB (Oxford) (2009) 0.75

Pancreatogastrostomy with an elastic purse-string suture around the gastric orifice after pancreatoduodenectomy. Surg Today (2009) 0.75

Articles by these authors

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med (2004) 13.34

Small (Sendai negative) branch-duct IPMNs: not harmless. Ann Surg (2012) 7.26

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA (2010) 6.65

Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery (2007) 6.62

Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med (2011) 6.50

No surgical innovation without evaluation: the IDEAL recommendations. Lancet (2009) 5.57

Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg (2013) 5.12

Colorectal cancer. Lancet (2005) 4.90

Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery (2007) 4.72

Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med (2010) 4.13

Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet (2011) 3.54

Recalling superior mesenteric artery syndrome. Dig Surg (2007) 3.52

IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology (2002) 3.48

Primary malignant hepatic epithelioid hemangioendothelioma: a comprehensive review of the literature with emphasis on the surgical therapy. Cancer (2006) 3.16

Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16

Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA (2012) 3.13

Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg (2003) 3.12

Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg (2011) 3.10

Evaluation and stages of surgical innovations. Lancet (2009) 3.04

Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Ann Surg (2011) 2.92

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA (2012) 2.88

Challenges in evaluating surgical innovation. Lancet (2009) 2.86

Most pancreatic cancer resections are R1 resections. Ann Surg Oncol (2008) 2.79

Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology (2008) 2.76

Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol (2014) 2.64

The role of stroma in pancreatic cancer: diagnostic and therapeutic implications. Nat Rev Gastroenterol Hepatol (2012) 2.59

Distal pancreatectomy: risk factors for surgical failure in 302 consecutive cases. Ann Surg (2007) 2.51

Laparoscopic versus open surgical techniques for ventral or incisional hernia repair. Cochrane Database Syst Rev (2011) 2.46

Role of colonoscopy and polyp characteristics in colorectal cancer after colonoscopic polyp detection: a population-based case-control study. Ann Intern Med (2012) 2.37

Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery (2009) 2.29

Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res (2003) 2.27

Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg (2008) 2.22

Periostin creates a tumor-supportive microenvironment in the pancreas by sustaining fibrogenic stellate cell activity. Gastroenterology (2007) 2.15

Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14

Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet (2013) 2.10

Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology (2010) 2.10

StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut (2011) 2.07

Elective midline laparotomy closure: the INLINE systematic review and meta-analysis. Ann Surg (2010) 2.06

The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol (2008) 2.05

Interrupted or continuous slowly absorbable sutures for closure of primary elective midline abdominal incisions: a multicenter randomized trial (INSECT: ISRCTN24023541). Ann Surg (2009) 2.03

Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg (2011) 2.02

Surgical treatment of patients with wandering spleen: report of six cases with a review of the literature. Surg Today (2007) 2.02

Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol (2011) 2.02

Liver stiffness is directly influenced by central venous pressure. J Hepatol (2009) 2.00

Diagnostic criteria and severity assessment of acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg (2007) 1.98

Interval cancers after negative colonoscopy: population-based case-control study. Gut (2011) 1.97

Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer. Gut (2011) 1.96

Hypoxia-inducible proto-oncogene Pim-1 is a prognostic marker in pancreatic ductal adenocarcinoma. Cancer Biol Ther (2008) 1.95

Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg (2008) 1.93

Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma. J Clin Oncol (2012) 1.90

A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet (2006) 1.90

Pouch vs. no pouch following total gastrectomy: meta-analysis and systematic review. Am J Gastroenterol (2009) 1.88

The "artery first" approach for resection of pancreatic head cancer. J Am Coll Surg (2009) 1.86

Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg (2007) 1.85

Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci U S A (2007) 1.85

Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma. Cancer Res (2006) 1.82

TG13 flowchart for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci (2013) 1.82

Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial. Ann Surg (2011) 1.81

Insertion of totally implantable venous access devices: an expertise-based, randomized, controlled trial (NCT00600444). Ann Surg (2011) 1.77

CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Ann Surg Oncol (2012) 1.76

Care after colonic operation--is it evidence-based? Results from a multinational survey in Europe and the United States. J Am Coll Surg (2005) 1.76

From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A (2009) 1.75

European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis (2013) 1.75

Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clin Cancer Res (2005) 1.74

Case-control study supports extension of surveillance interval after colonoscopic polypectomy to at least 5 yr. Am J Gastroenterol (2007) 1.74

Combined laparoscopic-endoscopic resections of colorectal polyps: 10-year experience and follow-up. Surg Endosc (2009) 1.74

Pancreatic cancer microenvironment. Int J Cancer (2007) 1.73

Adenocarcinomas of the esophagogastric junction are more likely to respond to preoperative chemotherapy than distal gastric cancer. Ann Surg Oncol (2011) 1.72

Impaired autolysosome formation correlates with Lamp-2 depletion: role of apoptosis, autophagy, and necrosis in pancreatitis. Gastroenterology (2009) 1.72

Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases. Ann Surg Oncol (2009) 1.70

Circulating tumor cells and prognosis of patients with resectable colorectal liver metastases or widespread metastatic colorectal cancer: a meta-analysis. Ann Surg Oncol (2013) 1.69

Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg (2007) 1.69

Pancreatic neuropathy and neuropathic pain--a comprehensive pathomorphological study of 546 cases. Gastroenterology (2008) 1.68

Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis. Oncogene (2005) 1.67

Telomerase gene mutations are associated with cirrhosis formation. Hepatology (2011) 1.67

TG13 guidelines for diagnosis and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci (2013) 1.66

Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells. Hepatology (2013) 1.62

Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg (2015) 1.62

Invasion and metastasis in pancreatic cancer. Mol Cancer (2003) 1.61

Improvement of surgical results for pancreatic cancer. Lancet Oncol (2013) 1.60